COVID-19 Testing: Possibilities & Challenges
Please join us Friday, May 29th, when we’ll host Dr. Joel Brill to discuss the current status of COVID-19 testing, treatment, and containment. Joel will explain how to identify FDA-authorized COVID-19 antibody tests and share insights on the current state of diagnostics, antibody testing, and vaccine development.
We encourage you to submit your questions in advance during registration to ensure we cover the issues that matter most to you.
About our speaker:
Joel V. Brill, MD FACP is an executive clinician with over 30 years of experience providing strategic leadership and medical oversight to large data-driven health organizations. He is skilled in strategy, development and implementation of innovative health programs, products and payment systems, with extensive experience in clinical practice, research, coverage, reimbursement, quality improvement, data analysis, and value-based care.
Dr. Brill is Board Certified in Internal Medicine and Gastroenterology. Dr. Brill has run risk-bearing Independent Practice Associations and Physician-Hospital Organizations in California and Arizona, held management positions with and participates on committees for several managed care companies. He was the Deputy Medical Director for the BFCC.NCC-QIO oversight project, serves on the Editorial Advisory Board for several journals, and was the co-founder of the AGA Center for GI Innovation and Technology.
Dr. Brill works extensively with the Centers for Medicare and Medicaid Services (CMS) and the American Medical Association (AMA) on coding, coverage and reimbursement issues, and co-Chaired the Part D medication measures Technical Expert Panel for CMS. He participates in the CPT Editorial Panel and the AMA RBRVS Update Committee (RUC), and has introduced over 180 CPT coding proposals. He has published extensively on episode and bundled payment methodologies, and has developed and submitted advanced payment models to the HHS Physician Focused Payment Model Technical Advisory Committee for consideration under MACRA.
Dr. Brill is an Assistant Clinical Professor of Medicine at the University of Arizona College of Medicine, and an Adjunct Assistant Professor of Medicine at Midwestern University. He has lectured at the School of Health Management & Policy at the WP Carey School of Business at Arizona State University.
Dr. Brill received his undergraduate A.B. Biology at the University of California, Los Angeles, and graduated from the Rosalind Franklin University of Medicine and Science - Chicago Medical School. He completed his Internship and Residency in Internal Medicine at the UCLA – San Fernando Valley Program, and a fellowship in Gastroenterology at Los Angeles County – USC Medical Center. Dr. Brill completed the Management Program for Health Care Organizations at the UCLA School of Public Health.